Literature DB >> 15108068

Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover.

Luisa Alvarez1, Jose-Vicente Torregrosa, Pilar Peris, Ana Monegal, Jose-Luis Bedini, Maria-Jesús Martinez De Osaba, Xavier Filella, Gloria Martin, Carmen Ricos, Federico Oppenheimer, Antonio-Manuel Ballesta.   

Abstract

The aim of the present study was to evaluate the effect of hemodialysis and renal failure on serum bone markers. Serum total alkaline phosphatase (TAP), procollagen type I aminoterminal propeptide (PINP), and beta-carboxyterminal telopeptide of type I collagen (beta-CTX), as well as intact parathyroid hormone (iPTH), creatinine, and total protein were measured in 14 patients with endstage renal disease (ESRD) before and at 1, 2, and 4 h during a hemodialysis session, and at the same sampling interval in 6 renal transplant recipients. The results were compared to those obtained in 20 healthy adults. All patients showed increased baseline mean values of PINP, beta-CTX, and iPTH. Beta-CTX differed significantly between hemodialysis patients and renal transplant recipients. TAP and beta-CTX were the only markers which correlated with iPTH ( P << 0.05) and creatinine values ( P << 0.001), respectively. Renal transplant recipients did not show significant variations in the evolution of mean values of bone markers throughout the study, whereas, during the dialysis period, all the bone markers analyzed in the study showed a significant change. The change differed depending on the marker considered: beta-CTX showed a significant decrease at the end of the session, TAP increased at this time and, although PINP showed an initial increase during hemodialysis, no significant changes were observed at the end of the session. We conclude that bone markers are significantly influenced by hemodialysis, especially serum TAP and beta-CTX. ESRD is associated with an increase in these bone markers, in some cases related to iPTH values and in others to glomerular function. These findings should be taken into account when evaluating bone markers in these patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108068     DOI: 10.1007/s00774-003-0476-9

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  5 in total

Review 1.  The Non-invasive Diagnosis of Bone Disorders in CKD.

Authors:  Jordi Bover; Pablo Ureña-Torres; Mario Cozzolino; Minerva Rodríguez-García; Carlos Gómez-Alonso
Journal:  Calcif Tissue Int       Date:  2021-01-04       Impact factor: 4.333

2.  Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.

Authors:  Syazrah Salam; Orla Gallagher; Fatma Gossiel; Margaret Paggiosi; Arif Khwaja; Richard Eastell
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

3.  Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation.

Authors:  Christina Wu; Tomoko S Kato; Katherine Pronschinske; Sylvia Qiu; Yoshifumi Naka; Hiroo Takayama; Ulrike Schulze-Späte; Serge Cremers; Elizabeth Shane; Donna Mancini; P Christian Schulze
Journal:  Eur J Heart Fail       Date:  2012-09-18       Impact factor: 15.534

Review 4.  Recent advances in the noninvasive diagnosis of renal osteodystrophy.

Authors:  Ranjani N Moorthi; Sharon M Moe
Journal:  Kidney Int       Date:  2013-06-26       Impact factor: 10.612

5.  Investigating the effective factors in creatinine changes among hemodialysis patients using the linear random effects model.

Authors:  B Shabankhani; A Kazemnezhad; F Zaeri
Journal:  J Med Life       Date:  2015
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.